The proliferation rate of tumour cells has so far been studied with methods such as 3H-thymidine/BrdU incorporation, mitotic index, or Ki-67/PCNA immunohistochemistry, but none of these tests has reached clinical application (Daidone and Silvestrini, 2001; Michels et al, 2004). Here, MKI67 is linked to neoplasm.